Taka Kubo

The Tech Ecosystem in Japan Platform isn’t just a showcase—it’s a collaborative ecosystem. Featuring 4,760 companies and 555 investors, it offers a unique opportunity for businesses, investors, and industry leaders to form strategic partnerships that drive innovation across sectors like AI, DeepTech, and HealthTech. We invite organizations interested in co-branding or becoming a significant part of this platform to connect with us. Whether you're looking to invest, partner, or be a key contributor to shaping Japan’s tech future, we'd love to explore how we can work together to amplify impact. Explore more here: https://lnkd.in/eEg3WKQG Let’s discuss how we can collaborate and create meaningful synergy. The University of Tokyo Kyoto University Osaka University Osaka Innovation Hub（大阪イノベーションハブ）Osaka University, Graduate School of Engineering Tohoku University National Institute of Advanced Industrial Science and Technology (AIST)

3

【2024 TMU BioMed Accelerator x SIC Joint Demo Day】Precision Healthcare and Sustainable Medicine TMU Biomed Accelerator and SIC are co-hosting the first joint Demo Day, featuring three biomedical startups from Taiwan and abroad: Bamboo Tech: A leader in mental health innovation, specializing in AI big data and voice emotion recognition. Developed the "Here Hear" mental health app, awarded the 2023 National Innovation Award and a bronze medal in the Ministry of Economic Affairs Invention Competition. Selected for the Microsoft for Startups Accelerator and AWE Women Entrepreneurs Accelerator. CytoArm: Developing a next-generation Armed-T cell technology platform for treating cancer and autoimmune diseases. Their first product (CTA-02) applied for clinical trials in Singapore this May to treat colorectal cancer. Two Armed-T products were licensed to a biotech company in 2023, with clinical trials expected to start in 2025. GuValue: Working on BNCT (Boron Neutron Capture Therapy), a targeted therapy technology that uses nuclear reactions to destroy tumor cells. Taiwan and Japan are the only two countries capable of performing this procedure. GuValue's partner, Dr. Yeh Gong-Ping, has extensive research experience, including contributions to the discovery of the top quark. Instant NanoBiosensors: Developing a highly sensitive blood testing platform using over 35 global patent technologies, revolutionizing the early diagnosis and post-treatment monitoring of neurodegenerative diseases. Selected for the NHS Global Competition team in 2022, with clinical collaborations and strategic partnerships showcasing their global influence. Pythia Biotech: Provides organ chips and personalized drug screening to reduce the burden of trial-and-error in cancer treatments. Their organ chips offer alternative options or virtual models for cancer patients. Featured on the cover story of "Integrative Biology" in 2015 and listed as a key medical diagnostics article in "Global Medical Discovery." Surgibox: Developed "SurgiField," a portable sterile environment for surgeries, protecting patients and healthcare professionals while reducing surgical risks. Funded by the U.S. Department of Defense and awarded the Canadian Humanitarian Challenge Award. The event will also include discussions on Precision Healthcare and Sustainable Medicine, moderated by Steve Lin, co-founder and partner at SIC, alongside Jowy Tani, MD, PhD, CEO of TMU BioMed Accelerator, and RuFen Chen, Industry Partner – Healthcare at SIC. 🔗Registration link: https://lnkd.in/g5X4pmCB 📆Date: June 27, 2024 (Thursday), 13:30 - 17:00 🏢Location: TMU BioMed Accelerator, Floor 5, Biomedical Science and Technology Building in Shuangho Campus, Yuan Tong Road No. 301, Zhonghe District, New Taipei City

5

How has the U.S. become the global market leader for AI in healthcare? Find out in Suzy Im’s latest Fortune Korea article: bit.ly/403PlKi and join us on October 23 at 8:00 PM ET (October 24 at 9:00 AM KT) for a LIVE discussion on how Key Opinion Leaders (KOLs) are key to success in the U.S. healthcare market: https://bit.ly/4d54mOY Featuring two AI adopters, Dr. Alexander Blood, MD, MSc, FACC of Brigham and Women's Hospital, and Dr. Danny Lee, MD FACP of Johns Hopkins Medicine, the article discusses how AI is changing the healthcare industry, the mistakes medical innovators make when expanding into the mainstream market, and the importance of KOLs in AI adoption. DM Suzy Im or email her at [email protected] to learn more about working with KOLs to introduce your innovative healthcare solutions in the U.S. #AI #AIadoption #Healthcare #AIhealthcare #Fortunekorea #Southkorea #DAC #Collaboration #Innovation #Korea #Healthcareinnovators #AIinnovators  #MedTech 

2

【5/27 Taiwan Life Sciences Biweekly - Top 10 News】 🔔 金寶集團 KINPO GROUP signs MOU with 臺中榮民總醫院 (Taichung Veterans General Hospital) for smart healthcare collaboration to involve developing telemedicine services, remote patient monitoring, smart operating rooms, intelligent command centers, AI healthcare, precision medicine, regenerative medicine, and advanced medical equipment.   🔔 The National Atomic Research Institute (#NARI) to install a 70 million electron volts (MeV) cyclotron to stabilize local supply of medical isotopes.   🔔 Advanced Genomics APAC Collaborates with Genomics BioSci & Tech Co Ltd to Expand Asia-Pacific Cancer Early Screening Markets.   🔔 Regenerative medicine company Xi Yue Biomedicine (formerly Guang Li Biomedicine) plans for allogeneic cell clinical trial for cerebral palsy, IPO for end of 2024.   🔔The 2024 BIO Convention will be held in person June 3-6, The Biotechnology and Pharmaceutical Industries Promotion Office (#BPIPO) and TAITRA Global (Taiwan External Trade Development Council) are organizing a Taiwan Pavilion to showcase Taiwan's exceptional biotechnology and medical R&D capabilities.    🔔 If Korea, which has advanced biotechnology, and Taiwan, which has large-scale clinical data on stem cell and gene therapy, work together, it will create great synergy: Sandy Wang, chairman of Taiwan's Formosa Group, said in a recent written interview with [South Korea's] Maeil Business. 🔔 順天醫藥生技股份有限公司 (Lumosa Therapeutics)' #LT3001 new drug clinical trial enrollment progressing well, unblinding by year-end planned. 🔔 The annual event of the global nutrition and health industry, Vitafoods Europe 2024, kicked off in Geneva on the 14th. TCM Biotech 泰宗生技 International showcased its research and development of its liver-protecting ingredient, LivPhcD. 🔔 Taiwan nutra market: Eye health, beauty, probiotics trending, with food firms, influencers entering business. 🔔 Taiwan-based vaccine maker Adimmune Corp (4142) signs benefit-sharing agreement with the World Health Organization (WHO) to receive early biological samples of emerging influenza variants. For details, please visit: https://lnkd.in/gw6qP4z6  

3

South Korea's Ministry of Health and Welfare and the Korea Health Industry Development Institute are seeking hospital participants in its pilot project to improve medical image exchange as the government outlined a four-year national medical AI research and development roadmap. #AIinHealth #HealthcareAI #DigitalTransformation

1

🏥 Calling Startups Revolutionizing Healthcare with AI 🤖 The future of healthcare is here, driven by the transformative power of Artificial Intelligence (AI). In Taiwan, the AI in healthcare market is on a meteoric rise, with a valuation of USD 15.3 billion in 2023 and a staggering projected worth of USD 194.35 billion by 2030, boasting a remarkable CAGR of 37.4%. Key Drivers of Innovation: 🌐 Government Support: The Taiwanese government is at the forefront of promoting AI adoption in healthcare, fostering research, establishing regulatory frameworks, and fostering public-private partnerships. 👴 Aging Population: With Taiwan's population rapidly aging, there's an increasing demand for healthcare services. AI emerges as a vital tool in addressing this challenge, automating tasks, enhancing diagnostics, and facilitating remote care. 🎯 Efficiency and Accuracy: AI-powered systems elevate healthcare delivery in Taiwan by enhancing efficiency and accuracy. From early disease detection through medical image analysis to streamlining clinical workflows, AI revolutionizes patient care. 📈 Growing Adoption of Telehealth: The COVID-19 pandemic has accelerated the adoption of telehealth in Taiwan, opening avenues for AI to revolutionize remote consultations, patient monitoring, and virtual assistance. Embrace the Future of Healthcare with AI: Join us in harnessing the power of AI to reshape the healthcare landscape in Taiwan. Together, we can drive innovation, improve patient outcomes, and build a healthier future for all. 🌐 Learn more about Mesh Digital Strategy 📧 Contact us: [email protected] or PM Shane Kao https://lnkd.in/gp5J73un #AIinHealthcare #TaiwanTech #Innovation #Telehealth #DigitalTransformation #HealthTech

2

We're very excited to be announcing our first seminar in a series focusing on AI innovations, with speakers from a diverse range of industries and backgrounds, in collaboration with Project X Vietnam. [WEBINAR] FRONTIERS IN AI: PIONEERING HEALTHCARE INNOVATIONS AND PROSPECTS FOR VIETNAM] - Are you curious about how AI is revolutionizing the healthcare industry, transforming disease diagnosis and treatment? - Are you interested in the immense potential of the healthcare sector and wellness industry in Vietnam? - Or perhaps you simply want to gain invaluable insights into the AI field from world-renowned experts? If so, don't miss this opportunity to attend our online seminar! ⏰ Time: 10:00 AM (GMT+7) on Sunday, May 19, 2024 (Vietnam time) 📍 Venue: Online via Zoom 👉 Registration link: https://lnkd.in/emPekwtA In this webinar, you will explore: - The Impact of AI: Applications of AI in disease diagnosis and treatment, from accurate prediction to optimizing treatment protocols. - Real-world Case Studies: How AI is being applied in global and Vietnamese healthcare systems. - Future Trends: Discussions on the potential developments of AI in the healthcare and wellness sectors. Here, you will have the privilege of meeting and learning from leading experts in the intersection of AI and healthcare. 1. Dr. Hieu (Hugh) Nguyen, PhD: Principal AI Scientist at UnitedHealth Group, the #1 global healthcare management company. With 10 years of experience across over 30 healthcare projects, collaborating with clinical teams, scientists, engineers, architects, statisticians, and project managers. Beyond academic research at The Johns Hopkins University and the University of Colorado, he has contributed to healthcare projects at Apple, Medtronic, Perthera, Inc., Teladoc Health, and UnitedHealth Group. He is fully committed to dedicating his life to improving and developing the healthcare technology industry. 2. Professor Wray Buntine: Director of the Computer Science program at VinUniversity. Previously, he was the Director of the Master of Data Science program at Monash University in Australia. He has conducted research projects at the Helsinki Institute of Information Technology (Finland), NASA - National Aeronautics and Space Administration Ames Research Center (USA), University of California, Berkeley, and Google. 💥 Host: Pemi N.: Director at Project X, CEO at AiLabs & Vice President at Innovators Hub Asia. He was an AI engineer at Meta and a former AI lecturer at the Paul G. Allen School of Computer Science & Engineering (Seattle, WA). Don't wait any longer! Register now to secure your spot at this invaluable event on the applications of AI in healthcare. Follow us for more exciting events in tech innovations! #AI #ML #Healthcare #VietnamTech #InnovatorsHub #Deeplearning

20

2件のコメント

"Technology does not equate to business. A professional system for commercialization is essential." “Although the venture studio model in the bio-healthcare field is not yet active in Korea, it is an essential model for the proper development of the industry ecosystem in the future. MINT Venture Partners will lead the startup, investment, and acceleration business in Korea.” During a panel discussion on the theme of ‘New Models for Successful Bio-healthcare Startups’ held during the ‘Bioplux-Interphex 2024’ in July, our Chairman & CEO Dr. Jae-Hoon Song (송재훈) emphasized the role of venture studios in the bio-healthcare startup ecosystem. The discussion gave us insights into the importance of creating synergy through collaboration with various experts such as medical professionals, business development experts, and investment experts, rather than sole dependence on the technology developers for the founding of startups. This collaborative ecosystem for bio-healthcare startups is currently lacking in Korea. Venture studio models, which are active in the US and in Europe, address the needs of startups by providing the expertise and the requisite network throughout a startup’s lifecycle. The involvement of clinical doctors is essential at every stage of the process, from technology development to commercialization, particularly in the bio-healthcare business. We provide Mint MD, which is a platform connecting the medical and industrial sectors. MintMD’s ‘Dr. Wiz’ provides expert advice and consulting by linking clinical medical experts with companies, and Mint MD’s ‘Dr. Match’ helps companies recruit medical experts. At Mint Venture Partners, we are committed to pioneering the venture studio model in Korea, ensuring that bio-healthcare startups have the support they need to thrive and innovate in this rapidly evolving industry. Special thanks to Korea BIO for organizing the conference, Dr. Young Hoon Kim for chairing the session, Seung Gyu Lee (Vice President, Korea BIO) and Junghwan Park (CEO, MEZOO) for the insightful discussion! 💡 #MINTVenturePartners #MintMD #Startup #VentureStudio #Healthcare #Biotech

36

Learn more about the IPO market in Taiwan!

6

IPO in Taiwan - it's such a topic so under the radar. I did an info session with Taiwan Stock Exchange and Startup Island TAIWAN last week in Singapore. Probably the first time I feel a 'PMF' as many audience came ask for my presentation deck after the session. Perhaps because exit is a big issue now in this region. When we see large unicorns face hard time justifying their market cap, let along those waiting in line. Some suggested, perhaps it's all better for M&A in this region. Well, M&A valuation could be even lower than you'd expect. That doesn't mean IPO is impossible. You only need a right market to do so. Taiwan equity market is our treasure, allowing 2,200+ companies to enjoy a super liquid market (US$15B a day and 250-350% trading turnover) and high P/E multiple (average 22x as of FY23, highest in APAC). Among them, 60% are tech companies. Aa a tech animal, you wanna be in the right forest, so you can attract the investors that are tech-savvy and understand you. (That's why Taiwan equity market is the 'Asian Nasdaq for small-mid cap'.) Not a Taiwan company? No worries, the listing rules require zero Taiwan asset, revenues, offices, officers, nothing. Because Taiwan itself made its economic miracle by making business outside! Since 2009 the deregulation, there are 115 non-Taiwan companies listed in Taiwan, with an average P/E at 28x and 240% trading turnover, metrics on par with those Taiwanese companies at similar size. It means, the market doesn't treat it differently. In my article, I'm very honoured that Kelvin Wee, the CEO of PATEC Precision Kft. (Hungary), a Signapore-registered company, is willing to share why they despite having zero presence and relationship with Taiwan chose to list in Taiwan. Main reasons include: strong liquidity, post-IPO fundraising, talent, regulatory support, and low costs. If you are interested, can read my articles for more details and data. I would also love to pay you a visit if you're indeed thinking about your exit target market. Article link: https://lnkd.in/gvdnr5SQ

129

8件のコメント

A meaningful partnership between digital technology and home healthcare has been achieved. Kakao Healthcare’s efforts to take care of the health of all citizens as a ‘national app’ used by 40 million people in Korea, combined with Bayada Home Health Care’s proven patient care service model, open the door to humanized digitalization. This will allow more patients and their families to connect with medical professionals in their communities and homes, manage their illnesses and lifestyles, and maintain a healthier life, providing high-quality home healthcare services. … Innovative home healthcare services that combine digital technology with home-based health care are expected to bring new vitality to the age of aging. Bayada Home Health Care (hereinafter referred to as Bayada) announced that it has signed a business agreement with Kakao Healthcare on the 20th and decided to develop a home health care service that combines digital technology and the touch of home-based medical professionals. #bayada #Homehealthcare #kakao #skillednursing https://lnkd.in/gFwtfCbr

34

5件のコメント

Bitcoin exceeded US$71,000 in March this year, setting a record high price. Currently, a large amount of cash is pouring into Bitcoin spot ETFs, which continues to drive the price of Bitcoin. Other crypto currencies are also driven higher by Bitcoin, including Ethereum. The price once exceeded US$4,000, and the U.S. SEC recently approved Form 19b-4 for multiple Ethereum spot ETFs. Although the S-1 registration statement needs to be effective before trading can begin, the future market of the currency has also been invested. Everyone is optimistic. I analyzed the market and investment market trends. Compared with the last bull market, the obvious increase in the number of new users is not so obvious this time. In other words, if people who are still in the currency circle can HODL and believe in crypto. If the market continues to have a bullish signal, he will invest money at this time, and he will continue to increase his investment. Therefore, the increase in the amount of this market mainly comes from people who have stayed in the crypto currency circle. No significant new users in 2024, but the critical mass may come in 2025. I mentioned that the current major challenge facing Taiwan's policy is that exchanges under Taiwan supervision there are only two or three revenue streams to make a profit. From a venture capital perspective, although this company is legal and compliant, its profit-making methods are very limited, and it also has to spend a lot of money to open servers, design products, optimize and update services, and deal with banks, etc., which further limits its profitability. VC will have less willingness to invest Taiwan-based exchanges. So how should Web3 and exchanges in Taiwan face these difficult hurdles? I said that investors could only live in HODL. Time will prove, so those who hold Bitcoin and Ethereum are "friends of time", and eventually market facts will prove that these people are right. In addition, I have been giving lectures all over the world for many years. I found that when giving lectures in schools in Taiwan, no matter what school or department they were in, very few people invested in crypto currency, let alone mentioned relevant knowledge in the field; But when I went to Singapore and Malaysia to give lectures, almost more than two-thirds of the students in a class were investing in crypto currency. "This has formed a very bad whirlpool in Taiwan. It may have a lot to do with the concepts instilled in traditional education, social values, and families. If everyone has a conservative and safe attitude towards emerging technologies and financial-related products, the consciousness "The formation will lead to a vicious cycle." I hope that the boom of this wave of cryptocurrency can change the overall environment, allow more people to join the ranks, and have a greater impact on the people around, especially the next generation. #cryptocurrency

59

2件のコメント

<For International Startups> 🚨 Last Call for International Startups!🚨 ☄️The deadline to apply for the Garage+ F24 Batch Startup Global Program is rapidly approaching!  Don’t miss out on this unique opportunity to accelerate your business growth in Taiwan and the wider Asian market. 🌏 Why apply? #Global_Market_Access: Showcase your innovative solutions to attract global opportunities. #Strategic_Connections: Meet influential decision-makers from industry leaders like TSMC, MediaTek, and more. #Investment_Opportunities: Secure funding from top venture capitalists in Taiwan and across Asia. 🗓️ Program Highlights: 🔸Fully funded 8-day trip with tailored 1-on-1 meetings. 🔸Exclusive startup exhibition for market exposure and potential collaboration. 🔸Bonus benefits such as flight subsidies and free workspace. ⚡️Don't miss your chance to scale up globally! Apply now and join the next wave of innovation. 👉🏻 Apply Now: https://lnkd.in/eRDJ_yuA - 🔻Learn more about our program and the successful cases: 🔹 Program Deck: https://reurl.cc/Gpm1Xp 🔹 Why Taiwan: https://reurl.cc/myLgZj 🔹 What is Garage+'s Open House: https://lnkd.in/enMsUh9v

36

🌟 Exciting times ahead for Taiwan's startup ecosystem! As we witness the growth and innovation emerging from this vibrant hub, it is clear that Taiwanese startups are not only thriving locally but also positioning themselves to make significant strides in the US market. With a robust network of incubators, accelerators, and an increasing flow of investment, Taiwan's entrepreneurs are equipped with the resources and potential to contribute meaningfully to the global landscape. Tech advancements, particularly in areas such as AI, biotechnology, and green energy, are paving the way for our startups to revolutionize industries across borders. As we pursue opportunities together, let us take pride in our collective mission to innovate, collaborate, and thrive in this new world market. By harnessing our unique strengths, we can create synergies that drive sustainable growth and bring transformative solutions to the international stage. Together, let’s embrace the future and explore the possibilities that lie ahead! #TaiwanStartups #Innovation #GlobalMarket #Entrepreneurship #TechForGood #Collaboration #Startups #BusinessGrowth #Sustainability

15

3件のコメント

Discover essential strategies for medical tech startups seeking venture capital in this latest feature on Dr Faith Lee's industry insights. Faith Lee, leveraging her experience as a physician, provides valuable advice on scaling medical technologies and navigating the complex healthcare market. Read this compelling Medium blog post to understand the pivotal role of venture capital in revolutionizing patient care and building strong medical tech companies. https://lnkd.in/eTzzAenk #lifesciences

1